Publications by authors named "Angelo Monti"

Claim this Profile
R
Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysis.
Najlaa Alyamani, André Abrunhosa-Branquinho, Coreen Corning, Marjan Sharabiani, Pierre Castadot, Angelo F Monti

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure.
Jonas Willmann, Joost J C Verhoeff, Orit Kaidar-Person, André Abrunhosa-Branquinho, Enrico Clementel, Angelo Filippo Monti

Radiother Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proof of concept of fully automated adaptive workflow for head and neck radiotherapy treatments with a conventional linear accelerator.
Gaia Muti, Marco M J Felisi, Angelo F Monti, Chiara Carsana, Roberto Pellegrini

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study.
Matthias Preusser, Tomáš Kazda, Emilie Le Rhun, Felix Sahm, Marion Smits, Angelo F Monti

Trials· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal evaluation of MLC models in treatment planning systems based on a common set of dynamic tests.
Jordi Saez, Raquel Bar-Deroma, Evelien Bogaert, Romain Cayez, Tom Chow, Angelo F Monti

Radiother Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Staged-Dose Gamma Knife Radiosurgery for the Treatment of Large Brain Metastases: Report of 40 Consecutive Cases and Analysis of Literature.
Francesco M Crisà, Filippo Leocata, Virginia M Arienti, Marco Picano, Luca Berta, Angelo F Monti

Neurol India· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI only in a patient with prostate cancer with bilateral metal hip prostheses: case study.
Marco Felisi, Angelo Filippo Monti, Domenico Lizio, Stefania Nici, Roberto Giuseppe Pellegrini

Tumori· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of staffing, workload and infrastructure in member departments of the European Organisation for Research and Treatment of Cancer (EORTC) radiation oncology group.
Jonas Willmann, Philip Poortmans, Angelo Fillipo Monti, Warren Grant, Enrico Clementel

Radiother Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gamma Knife Radiosurgery for Treatment of Brain Metastases during the COVID-19 Outbreak.
Francesco Maria Crisà, Filippo Leocata, Virginia Maria Arienti, Marco Picano, Luca Berta, Angelo Filippo Monti

Stereotact Funct Neurosurg· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
Romaana Mir, Sarah M Kelly, Ying Xiao, Alisha Moore, Catharine H Clark, Angelo F Monti

Radiother Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A virtual dosimetry audit - Towards transferability of gamma index analysis between clinical trial QA groups.
Mohammad Hussein, Enrico Clementel, David J Eaton, Peter B Greer, Annette Haworth, Angelo F Monti

Radiother Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
Melissa Christiaens, Sandra Collette, Jens Overgaard, Vincent Gregoire, Joanna Kazmierska, Angelo F Monti

Radiother Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of potential improvements using MRI in the radiotherapy workflow.
Alberto Torresin, Maria Grazia Brambilla, Angelo F Monti, Alessio Moscato, Marc A Brockmann

Z Med Phys· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group.
Warren Grant, Coen W Hurkmans, Philip M Poortmans, Philippe Maingon, Angelo F Monti

Radiother Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term rectal function after high-dose prostatecancer radiotherapy: results from a prospective cohort study.
Gianni Fellin, Tiziana Rancati, Claudio Fiorino, Vittorio Vavassori, Paolo Antognoni, Angelo F Monti

Radiother Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Set-up errors and planning target volume margins in head and neck cancer radiotherapy: a clinical study of image guidance with on-line cone-beam computed tomography.
Francesco Dionisi, Mauro Filippo Palazzi, Francesco Bracco, Maria Grazia Brambilla, Claudia Carbonini, Angelo Filippo Monti

Int J Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gantry angle dependence in IMRT pre-treatment patient-specific quality controls.
Angelo Filippo Monti, Chiara Berlusconi, Stefania Gelosa

Phys Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions.
Claudio Fiorino, Tiziana Rancati, Gianni Fellin, Vittorio Vavassori, Emanuela Cagna, Angelo Filippo Monti

Int J Radiat Oncol Biol Phys· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial.
Riccardo Valdagni, Vittorio Vavassori, Tiziana Rancati, Gianni Fellin, Micaela Baccolini, Angelo Filippo Monti

Radiother Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome.
Riccardo Valdagni, Michael W Kattan, Tiziana Rancati, Changhong Yu, Vittorio Vavassori, Angelo F Monti

Int J Radiat Oncol Biol Phys· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer.
Tiziana Rancati, Claudio Fiorino, Gianni Fellin, Vittorio Vavassori, Emanuela Cagna, Angelo Filippo Monti

Radiother Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study.
Gianni Fellin, Claudio Fiorino, Tiziana Rancati, Vittorio Vavassori, Micaela Baccolini, Angelo Filippo Monti

Radiother Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.
Tom Budiharto, Elena Musat, Philip Poortmans, Coen Hurkmans, Angelo Monti

Radiother Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
Riccardo Valdagni, Tiziana Rancati, Claudio Fiorino, Gianni Fellin, Alessandro Magli, Angelo F Monti

Int J Radiat Oncol Biol Phys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.
Vittorio Vavassori, Claudio Fiorino, Tiziana Rancati, Alessandro Magli, Gianni Fellin, Angelo F Monti

Int J Radiat Oncol Biol Phys· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis